CAS 210110-90-0
:3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochlorid (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride, (2R,3R,4R,5S)-
- Miglustat HCl
- Miglustat hydrochloride
N-(n-Butyl)-1-deoxynojirimycin hydrochloride
CAS:N-(n-Butyl)-1-deoxynojirimycin hydrochlorideFormel:C10H21NO4·ClHReinheit:>99%Farbe und Form:Solid-CrystalsMolekulargewicht:255.738983,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
CAS:Formel:C10H22ClNO4Reinheit:98%Farbe und Form:SolidMolekulargewicht:255.7390(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFormel:C10H21NO4·ClHReinheit:98%Farbe und Form:SolidMolekulargewicht:255.73898Miglustat hydrochloride
CAS:Miglustat hydrochlorideFormel:C10H22ClNO4Reinheit:≥98%Molekulargewicht:255.742Miglustat HCl
CAS:Formel:C10H21NO4·HClFarbe und Form:White To Off-White SolidMolekulargewicht:219.28 36.46Miglustat HCl
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFormel:C10H22ClNO4Reinheit:98%Molekulargewicht:255.74N-Butyldeoxynojirimycin Hydrochloride
CAS:Kontrolliertes ProduktApplications An inhibitor of a-glucosidase 1 as well as being an inhibitor of HIV cytopathicity. N-Butyldeoxynojirimycin has recently been used to retard lipid storage in the central nervous system of an animal model of Tay-Sachs disease.1-Deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.
References Hettkamp, H., et al.: Eur. J. Biochem., 142, 85 (1984), Szumilo, T., et al.: Arch. Biochem. Biophys., 247, 261 (1986), Fleet, G.W.J., et al.: FEBS Letters, 237, Number 1,2, 128 (1988), Kolter, T., et al.: Angew. Chem. Int. Ed. Engl., 36, 1955 (1997),Formel:C10H21NO4·ClHFarbe und Form:NeatMolekulargewicht:255.74N-Butyldeoxynojirimycin hydrochloride
CAS:Competitive inhibitor of ceramide-glycosyltransferase used for substrate reduction therapy in lysosomal storage disorders. It inhibits glucosylceramide synthase, which catalyses the initial step in glycosphingolipid biosynthetic pathway. This compound delays the onset of symptoms in type 1 Gaucher disease, Sandhoff disease and Tay-Sachs disease. It also reduces brain abnormalities in mucolipidosis type IV.
Formel:C10H21NO4•HClReinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:255.74 g/molMiglustat hydrochloride
CAS:Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I GaucherFormel:C10H22ClNO4Reinheit:99.85%Farbe und Form:SolidMolekulargewicht:255.74Ref: TM-TQ0155
1mg38,00€5mg84,00€1mL*10mM (DMSO)93,00€10mg130,00€25mg245,00€50mg385,00€100mg557,00€200mg790,00€









